ISPOR Announces Its 6th Latin America Conference Plenary Sessions and Speakers

Published Jun 20, 2017

Theme Centered on Driving Better Health Outcomes Through Stakeholder Engagement

Princeton, NJ—June 20, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the plenary sessions and speakers for its 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil. The conference will examine health system reform and sustainability, patient engagement in health care decision making, drug development, and regulatory issues through the lens of the theme, Driving Better Health Outcomes Through Stakeholder Engagement. Conference Co-Chairs include Stephen Doral Stefani, MD, UNIMED; Marcelo Fonseca, MD, MSc, PhD, Federal University of São Paulo; Rosa María Galindo-Suárez, MHE, Mexican Ministry of Health. The first plenary session, Latin American Health Systems Reform: Opportunities and Challenges, is scheduled for Saturday, 16 September 2017. This session will concentrate on the current status, related challenges, and future opportunities of health systems reform in Latin America as a number of countries in the region work to implement universal health care coverage. The plenary features:
  • Eduardo Gonzalez-Pier, PhD, Distinguished Visiting Fellow, Center for Global Development, Washington D.C. (moderator)
  • Jesús Ancer Rodríguez, MD, Secretary, General Health Council, Mexico City, Mexico
  • Rubén Torres, MD, PhD, Dean, ISALUD University, Buenos Aires, Argentina
  • Mauricio Vargas Fuentes, MD, MSc, University of Costa Rica and Latin America Alliance for Global Health, San Pedro, San Jose, Costa Rica
The second plenary session, The Voice of the Patient: Hearing Their Perspective and Incorporating in the Decision-Making Process, is scheduled for Sunday, 17 September 2017. This session will explore the challenges faced and opportunities available to more effectively bring the patient perspective into health care decision making. The plenary features:
  • Federico Augustovski, MD, MSc, PhD, 2017-2018 ISPOR President-Elect and Director, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina (moderator)
  • Eleanor Perfetto, RPh, PhD, MS, Senior Vice President, Strategic Initiatives, National Health Council, Washington, DC, USA
  • Migdalia Denis, MA, President, Pulmonary Hypertension Society for Latin America, Board member of International Alliance of Patient Organizations (IAPO), Miami, Florida, USA
  • Aline Silveira Silva, Executive Secretariat of the National Committee for Health Technology Incorporation – CONITEC, Brasilia, Brazil
ISPOR is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in health care decision making. The ISPOR 6th Latin America Conference will host health care stakeholders from the region, including health ministries and government offices, health technology assessment bodies, public and private payers, researchers and academics, and patients and patient representatives. The conference also features the Society’s renowned Essential HEOR Education Short Course Program offering 8 half-day short courses on 15 September 2017. A variety of issue panels, workshops, forums, educational symposia, podium presentations, and poster presentations will also be featured. Additional information on the conference can be found at: Conference Information | Registration | Short Course Program |Sponsorship | Exhibitors | Press

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB    

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×